In a recent Fox News interview, Kennedy said "there's a lot of studies out there that show that if you actually do get the wild infection, you're protected later. It boosts your immune system later in ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval ...

Kevin Samuels' net worth at death was a testament to his illustrious career as an image consultant and social internet ...